Filing Details

Accession Number:
0001209191-14-053388
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-19 16:30:26
Reporting Period:
2014-08-18
Filing Date:
2014-08-19
Accepted Time:
2014-08-19 16:30:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368148 Athersys Inc / New ATHX Pharmaceutical Preparations (2834) 204864095
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352452 Lorin Randall 3201 Carnegie Avenue
Cleveland OH 44115
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-18 15,000 $1.35 15,000 No 4 M Direct
Common Stock Disposition 2014-08-18 15,000 $1.54 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director stock option (right to purchase) Disposition 2014-08-18 15,000 $0.00 15,000 $1.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-09-09 No 4 M Direct
Footnotes
  1. Shares sold upon exercise of 2009 director stock option award prior to its expiration date on September 9, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.505 to $1.562, inclusive. The reporting person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. The 2009 director stock option award became fully exercisable on September 9, 2012.